ERRATUM
Published on 31 Aug 2020
Erratum: Editorial: NKT Cells in Cancer Immunotherapy
doi 10.3389/fimmu.2020.594504
- 1,544 views
- Frontiers in Immunology
- Cancer Immunity and Immunotherapy
- Research Topics
- NKT Cells in Cancer Immunotherapy
NKT Cells in Cancer Immunotherapy
30k
Total Downloads
146k
Total Views and Downloads
Submit your idea
Select the journal/section where you want your idea to be submitted:
Articles
EDITORIAL
Published on 23 Jun 2020
Editorial: NKT Cells in Cancer Immunotherapy
doi 10.3389/fimmu.2020.01314
- 7,449 views
- 18 citations
MINI REVIEW
Published on 06 Jun 2019
α-GalCer and iNKT Cell-Based Cancer Immunotherapy: Realizing the Therapeutic Potentials
doi 10.3389/fimmu.2019.01126
- 16,735 views
- 57 citations
REVIEW
Published on 02 Mar 2018
Novel Approaches to Exploiting Invariant NKT Cells in Cancer Immunotherapy
doi 10.3389/fimmu.2018.00384
- 19,090 views
- 120 citations
REVIEW
Published on 22 Feb 2018
Possible Therapeutic Application of Targeting Type II Natural Killer T Cell-Mediated Suppression of Tumor Immunity
doi 10.3389/fimmu.2018.00314
- 4,196 views
- 15 citations
REVIEW
Published on 10 Jan 2018
The Yin and Yang of Invariant Natural Killer T Cells in Tumor Immunity—Suppression of Tumor Immunity in the Intestine
doi 10.3389/fimmu.2017.01945
- 3,999 views
- 19 citations
ORIGINAL RESEARCH
Published on 05 Jan 2018
Neurofibromin 1 Impairs Natural Killer T-Cell-Dependent Antitumor Immunity against a T-Cell Lymphoma
doi 10.3389/fimmu.2017.01901
- 3,946 views
- 9 citations
REVIEW
Published on 22 Dec 2017
Natural Killer T Cells: An Ecological Evolutionary Developmental Biology Perspective
doi 10.3389/fimmu.2017.01858
- 18,499 views
- 63 citations
REVIEW
Published on 18 Dec 2017
Harnessing the Power of Invariant Natural Killer T Cells in Cancer Immunotherapy
doi 10.3389/fimmu.2017.01829
- 7,421 views
- 47 citations
PERSPECTIVE
Published on 08 Nov 2017
New Directions for Natural Killer T Cells in the Immunotherapy of Cancer
doi 10.3389/fimmu.2017.01480
- 3,562 views
- 6 citations
REVIEW
Published on 01 Nov 2017
Mixed Signals: Co-Stimulation in Invariant Natural Killer T Cell-Mediated Cancer Immunotherapy
doi 10.3389/fimmu.2017.01447
- 6,794 views
- 19 citations
MINI REVIEW
Published on 01 Nov 2017
Alpha-Galactosylceramide/CD1d-Antibody Fusion Proteins Redirect Invariant Natural Killer T Cell Immunity to Solid Tumors and Promote Prolonged Therapeutic Responses
doi 10.3389/fimmu.2017.01417
- 3,113 views
- 13 citations
Published in
Frontiers in Immunology
- Cancer Immunity and Immunotherapy
Participating Journals
Frontiers in Oncology
- 3.5 impact factor
- 6.2 citescore
Impact
- 146kTopic views
- 109kArticle views
- 30kArticle downloads